Italy Minimally Invasive Surgical Instruments Market Trends 2019 | Segmentation, Outlook, Industry Report to 2025

Italy minimally invasive surgical (MIS) instruments market is expected to grow at a CAGR of around 6.8% during the forecast period. Significant incidences of cancer are driving the growth of the market in the country. According to the International Agency for Research on Cancer (IARC), the number of new incidences of cancer reported in Italy was 409,808 in 2018. Lung cancer is one of the leading causes of cancer deaths in men and women in Italy. The new incidences of lung cancer reported in Italy were 39,989. It is 9.8% of the total new cancer incidences in the country. This leads the demand for effective treatment options with the rising lung cancer deaths and ageing population.

To Request a Sample of our Report on Italy Minimally Invasive Surgical Instruments Market: https://www.omrglobal.com/request-sample/italy-minimally-invasive-surgical-instruments-market

As a result, the adoption of minimally invasive thoracic surgery has been reported in Italy for the treatment of lung and respiratory disorders. According to the National Center for Biotechnology Information (NCBI), in Italy, there is a rich and long history in minimally invasive thoracic surgery. The major Italian surgeons have been the first who initially used video-assisted thoracic surgery (VATS) for performing procedures, such as esophagectomy and lobectomy, respectively as well as proposed breakthrough ideas and creative technical refinements. Moreover, up to September 2015, Italian VATS group registry gathered a total number of 1,688 thoracoscopic lobectomies performed in more than 70 Italian Institutions. There has been rapid adoption of VATS lobectomy in Italy and various thoracic surgeons are now involved in active VATS lobectomy programs necessitating the utilization of multiport or uniportal methods. VATS lobectomy is also used as a surgical treatment of lung cancer. Hence, it enables to boost the market in Italy.

(Get 15% Discount on Buying this Report)

A full Report of Italy Minimally Invasive Surgical Instruments Market is Available at: https://www.omrglobal.com/industry-reports/italy-minimally-invasive-surgical-instruments-market

Italy Minimally Invasive Surgical Instruments Market Segmentation

By Product

· Inflation Systems

· Cutter Instruments

· Guiding Devices

· Handheld Instruments

· Stents

· Sutures

· Monitoring and Visualization Equipment

· Robotic Assisted Surgical Systems

By Technology

· Endoscopy

· Laparoscopy

· Robot-Assisted Methods

· Arthroscopic Techniques

· Ablative Methods

By Application

· Cardiac Surgery

· Colorectal Surgery

· Dermatological Surgery

· ENT Surgery

· Gastrointestinal Surgery

· Gynecological Surgery

· Lung & Respiratory Care

· Neurosurgery

· Ophthalmology

· Orthopedics

· Others

Company Profiles

· Abbott Laboratories, Inc.

· B. Braun Melsungen AG

· Boston Scientific Corp.

· Edwards Lifesciences Corp.

· Medtronic plc

· Smith & Nephew plc

· Stryker Corp.

· Teleflex, Inc.

· Terumo Medical Corp.

· TransEnterix, Inc.

· Vigeo Srl

Reasons to Buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/italy-minimally-invasive-surgical-instruments-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.